Jpmorgan Chase & Co »

ALNYLAM PHARMACEUTICALS INC. Common Stock cmn shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of ALNYLAM PHARMACEUTICALS INC. Common Stock cmn shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in ALNYLAM PHARMACEUTICALS INC. Common Stock cmn

Tip: Access up to 7 years of quarterly data

All positions including ALNYLAM PHARMACEUTICALS INC. Common Stock cmn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ALNYLAM PHARMACEUTICALS INC. Common Stock cmn by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.8M 20k 191.41
2023-06-30 $1.4M 7.5k 189.94
2023-03-31 $1.5M 7.5k 200.27
2022-06-30 $12M 84k 145.85
2022-03-31 $12M 71k 163.30
2021-12-31 $33M 193k 169.58
2020-12-31 $1.3M 10k 130.00
2019-06-30 $15M 215k 71.08
2018-09-30 $2.6M 30k 87.53
2018-06-30 $2.7M 27k 98.48
2018-03-31 $3.2M 27k 119.11

Top funds holding ALNYLAM PHARMACEUTICALS INC. Common Stock cmn